Timber Pharmaceuticals Inc (TMBR) Stock Decreases -3.01% This Week; Should You Buy?

Tuesday, December 06, 2022 03:21 PM | InvestorsObserver Analysts

Mentioned in this article

Timber Pharmaceuticals Inc (TMBR) Stock Decreases -3.01% This Week; Should You Buy?

Timber Pharmaceuticals Inc (TMBR) stock has fallen -93.21% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives TMBR stock a score of 0 out of a possible 100.

That rank is chiefly influenced by a short-term technical score of 0. TMBR's rank also includes a long-term technical score of 0.

TMBR has an Overall Score of 0. Find out what this means to you and get the rest of the rankings on TMBR!

See Full TMBR Report

What's Happening with TMBR Stock Today

Timber Pharmaceuticals Inc (TMBR) stock is lower by -11.64% while the S&P 500 has fallen -1.77% as of 3:05 PM on Tuesday, Dec 6. TMBR has fallen -$0.17 from the previous closing price of $1.46 on volume of 79,621 shares. Over the past year the S&P 500 has fallen -14.45% while TMBR has fallen -93.21%. TMBR lost -$13.99 per share in the over the last 12 months. Click Here to get the full Stock Report for Timber Pharmaceuticals Inc stock.